JP2004506695A - う蝕の予防の免疫学的方法 - Google Patents

う蝕の予防の免疫学的方法 Download PDF

Info

Publication number
JP2004506695A
JP2004506695A JP2002520852A JP2002520852A JP2004506695A JP 2004506695 A JP2004506695 A JP 2004506695A JP 2002520852 A JP2002520852 A JP 2002520852A JP 2002520852 A JP2002520852 A JP 2002520852A JP 2004506695 A JP2004506695 A JP 2004506695A
Authority
JP
Japan
Prior art keywords
treating
monoclonal antibody
dental caries
mammal
preventing dental
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002520852A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004506695A5 (https=
Inventor
シー，ウェニュアン
アンダーソン，マックスウェル，エイチ．
Original Assignee
ワシントン　デンタル　サービス
リージェンツ　オブ　ザ　ユニバーシティ　オブ　カリフォルニア
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ワシントン　デンタル　サービス, リージェンツ　オブ　ザ　ユニバーシティ　オブ　カリフォルニア filed Critical ワシントン　デンタル　サービス
Publication of JP2004506695A publication Critical patent/JP2004506695A/ja
Publication of JP2004506695A5 publication Critical patent/JP2004506695A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Gram-positive bacteria
    • C07K16/1275—Streptococcus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/86—Products or compounds obtained by genetic engineering
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Botany (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
JP2002520852A 2000-08-24 2000-08-24 う蝕の予防の免疫学的方法 Pending JP2004506695A (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2000/023277 WO2002015931A1 (en) 2000-08-24 2000-08-24 Immunologic method for the prevention of dental caries

Publications (2)

Publication Number Publication Date
JP2004506695A true JP2004506695A (ja) 2004-03-04
JP2004506695A5 JP2004506695A5 (https=) 2005-03-17

Family

ID=21741708

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002520852A Pending JP2004506695A (ja) 2000-08-24 2000-08-24 う蝕の予防の免疫学的方法

Country Status (4)

Country Link
EP (1) EP1313506A1 (https=)
JP (1) JP2004506695A (https=)
AU (1) AU2000270698A1 (https=)
WO (1) WO2002015931A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030143234A1 (en) * 1999-08-20 2003-07-31 Wenyuan Shi Anti-microbial targeting chimeric pharmaceutical
US20020068066A1 (en) * 1999-08-20 2002-06-06 Wenyuan Shi Method for the treatment and prevention of dental caries
US7569542B2 (en) 1999-08-20 2009-08-04 The Regents Of The University Of California Anti-microbial targeting chimeric pharmaceutical
US7875598B2 (en) 2004-03-04 2011-01-25 The Regents Of The University Of California Compositions useful for the treatment of microbial infections
US7846895B2 (en) 2006-09-06 2010-12-07 The Regents Of The University Of California Selectively targeted antimicrobial peptides and the use thereof

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05502587A (ja) * 1990-07-05 1993-05-13 セルテック　リミテッド Ｃｄｒグラフト抗―ｃｅａ抗体およびその製造方法
US5352446A (en) * 1986-03-25 1994-10-04 Council Of Governors Of The United Medical And Dental Schools Of Guy's And St. Thomas's Hospitals Method of treating dental caries with monoclonal antibodies against the antigen I and antigen I/II of streptococcus mutans
JPH11504901A (ja) * 1994-12-30 1999-05-11 プラネット・バイオテクノロジー・インコーポレイテッド 植物における防御タンパク質を含む免疫グロブリンの製造法およびその使用
WO2000011037A1 (en) * 1998-08-21 2000-03-02 The Regents Of The University Of California Monoclonal antibodies specific for streptococcus mutans, and uses thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6028937A (ja) * 1983-07-25 1985-02-14 Kitasato Inst:The 非う蝕性抗体および組成物
JPS6038329A (ja) * 1983-08-11 1985-02-27 Lion Corp う蝕予防剤
JP2641228B2 (ja) * 1988-01-22 1997-08-13 鐘紡株式会社 抗体およびそれを有効成分とするう蝕予防剤、並びにこれらの製造方法
JPH02177899A (ja) * 1988-12-28 1990-07-10 Nagase Sangyo Kk スオレプトコッカス・ミュータンスに特異的に反応するＩｇＤモノクローナル抗体
JPH05227916A (ja) * 1992-01-11 1993-09-07 Kanebo Ltd う蝕予防食品
JPH06122633A (ja) * 1992-10-09 1994-05-06 Lion Corp ストレプトコッカス・ミュータンスに対して免疫活性を有する抗体及びう蝕予防剤
US6046037A (en) * 1994-12-30 2000-04-04 Hiatt; Andrew C. Method for producing immunoglobulins containing protection proteins in plants and their use

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5352446A (en) * 1986-03-25 1994-10-04 Council Of Governors Of The United Medical And Dental Schools Of Guy's And St. Thomas's Hospitals Method of treating dental caries with monoclonal antibodies against the antigen I and antigen I/II of streptococcus mutans
JPH05502587A (ja) * 1990-07-05 1993-05-13 セルテック　リミテッド Ｃｄｒグラフト抗―ｃｅａ抗体およびその製造方法
JPH11504901A (ja) * 1994-12-30 1999-05-11 プラネット・バイオテクノロジー・インコーポレイテッド 植物における防御タンパク質を含む免疫グロブリンの製造法およびその使用
WO2000011037A1 (en) * 1998-08-21 2000-03-02 The Regents Of The University Of California Monoclonal antibodies specific for streptococcus mutans, and uses thereof

Also Published As

Publication number Publication date
WO2002015931A1 (en) 2002-02-28
EP1313506A1 (en) 2003-05-28
WO2002015931A9 (en) 2002-05-23
AU2000270698A1 (en) 2002-03-04

Similar Documents

Publication Publication Date Title
Abiko Passive immunization against dental caries and periodontal disease: development of recombinant and human monoclonal antibodies
CA2303202C (en) Amino acid sequences for therapeutical and prophylactic applications to diseases due to clostridium difficile toxins
JP5923186B2 (ja) 有用な抗体を発現する雑種細胞の作成方法
US20050014931A1 (en) Human antipneumococcal antibodies from non-human animals
JP2009148280A (ja) エピトープへの結合能力を保持する結合部位ドメインの同定のための新規方法
EP1230269A2 (en) Antibody diversity generation
JPH06501152A (ja) 動物およびヒトにおける感染の治療および予防用の新規な抗体
JPH06217786A (ja) 抗ネコヘルペスウイルス−１組換え抗体および該抗体をコードする遺伝子断片
CZ394297A3 (cs) Streptokokové proteiny teplotního šoku ze skupiny HSP70
US20020068066A1 (en) Method for the treatment and prevention of dental caries
WO1993011791A1 (en) Antigenic preparations that stimulate production of antibodies which bind to the pili of type iv piliated bacteria
JP2004514423A (ja) トランスジェニックｘｅｎｏｍｏｕｓｅ（登録商標）から獲得されるｐｅｕｄｏｍｏｎａｓａｅｒｕｇｉｎｏｓａｌｐｓに対するヒト抗体
JP2004506695A (ja) う蝕の予防の免疫学的方法
JP2001510329A (ja) ヒトモノクローナル抗体
KR20130020393A (ko) 포르피로모나스 진지발리스(Ｐｏｒｐｈｙｒｏｍｏｎａｓ ｇｉｎｇｉｖａｌｉｓ)의 ＦｉｍＡ 단백질 특이적 결합성을 갖는 항체, 항체를 코딩하는 유전자 및 항체를 포함하는 치주질환 치료용 조성물
DE69932719T2 (de) Humanisierte Antikörper zur Erkennung von Verotoxin II sowie Zelllinie zur Herstellung derselben
JP3514482B2 (ja) 抗ネコカリシウイルス組換え抗体および該抗体からなる治療剤
KR100506118B1 (ko) 수막염균증 백신 조성물
JPH0411897A (ja) 抗緑膿菌外毒素ａヒトモノクローナル抗体
US20070031409A1 (en) Recombinant DNA-molecule complex for the expression of anti-human-interferon-gamma chimeric antibodies or antibody fragments
MXPA00002491A (en) Amino acid sequences for therapeutical and prophylactic applications to diseases due to clostridium difficile
EA046539B1 (ru) Системы и способы получения в-клеток, генетически модифицированных, для экспрессии выбранных антител

Legal Events

Date Code Title Description
A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20060911

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20060913

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20070710

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100615

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20101124